D-0235-2015 Class III Terminated
FDA drug recall D-0235-2015 was initiated by Pfizer Inc. on Oct 10, 2014 and is designated Class III. Reason for recall: Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this… The recall status is terminated (terminated Apr 14, 2017). Affected quantity: 16,000 kits.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 12, 2014
- Initiation Date
- Oct 10, 2014
- Termination Date
- Apr 14, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 16,000 kits
Product description
TORISEL Kit (temsirolimus) injection, 25 mg/mL, 1 vial of TORISEL 25 mg/mL and 1 vial of 2.2 mL DILUENT per carton, Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101; Diluent MADE IN ITALY; NDC 0008-1179-01.
Reason for recall
Crystallization: Impurities in a raw material used to manufacture the diluent can cause the formation of crystals in the diluent vials after cold storage. The TORISEL vials are not affected by this issue.
Distribution pattern
Nationwide and Puerto Rico
Code information
Kit Lot #: AIEM/13, Exp 05/16 that contain diluent lots AHZW/11 and AHZW/12
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0235-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026